IP Library › Granted Patent US 10,946,197
Granted Patent B2
US 10,946,197 · App. 12/774,616 · Granted Mar 16, 2021

Treatment of conditions through modulation of the autonomic nervous system

Inventors: Anthony Joonkyoo Yun (Palo Alto, CA); Patrick Yuarn-Bor Lee (Menlo Park, CA)
Assignee: Palo Alto Investors
A61N1/36053A61N1/0551A61N1/326A61N1/3605A61N1/36017A61N1/36071A61N1/36117A61N1/37235A61N1/36021
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,946,197
App. No.
12/774,616
Granted
Mar 16, 2021
Kind
B2
Abstract

Methods are provided for treating a subject for a condition by modulating at least a portion of the subject's autonomic nervous system. In accordance with certain embodiments of the subject methods, at least a portion of a subject's autonomic nervous system is electrically or pharmacologically modulated in a manner that is effective to treat the subject for the condition. The subject methods find use in the treatment of a variety of different conditions, where such conditions include various disease conditions. Also provided are systems and kits for use in practicing the subject methods.

Claims (6)

1. A method of treating a subject for a condition associated with a systemic loss of parasympathetic function, the method comprising:

measuring the subject's parasympathetic/sympathetic activity ratio to detect that the subject has the systemic loss of parasympathetic function; and

electrically modulating at least a portion of the parasympathetic nervous system of the subject, based on the subject's detected systemic loss of parasympathetic function, with an electrical energy application device to modulate the parasympathetic activity/sympathetic activity ratio in a manner effective to treat said subject for the condition, wherein the condition is multi-system atrophy.

2. A method of treating a subject for a condition associated with a systemic loss of parasympathetic function, the method comprising:

measuring the subject's parasympathetic/sympathetic activity ratio to detect that the subject has the systemic loss of parasympathetic function; and

administering a pharmacological agent to the subject, based on the subject's detected systemic loss of parasympathetic function, sufficient to provide systemic pharmacological modulation of said subject's autonomic nervous system to modulate the parasympathetic activity/sympathetic activity ratio in a manner effective to treat said subject for the condition, wherein the condition is multi-system atrophy.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 16, 2010
From: YUN, ANTHONY JOONKYOO; LEE, PATRICK YUARN-BOR
To: PALO ALTO INVESTORS
Reel/Frame 024842/0726 →
Continuity (8)
Continuation 11060643 · Feb 16, 2005
Continuation In Part 10871366 · Jun 18, 2004
Continuation In Part 10661368 · Sep 12, 2003
Provisional Application 60547955 · Feb 25, 2004
Provisional Application 60477070 · Jun 9, 2003
Provisional Application 60482593 · Jun 24, 2003
Provisional Application 60494260 · Aug 11, 2003
Related Publication 20100286734A1 · Nov 11, 2010
Cited By (1)
US 12,458,427